Numelvi 4.8 mg Tablets for Dogs

None.

Special precautions for safe use in the target species:
Safety of this veterinary medicinal product has not been investigated in dogs younger
than 6 months of age or weighing less than 3 kg. Use of the veterinary medicinal
product in younger animals or animals with a lower bodyweight should be based on a
benefit-risk assessment by the responsible veterinarian.
Complicating factors such as bacterial, fungal or parasitic infections (e.g., fleas,
Demodex mites), in addition to any underlying causes of allergic and atopic
dermatitis (e.g., flea allergy, contact allergy, food allergy) should be investigated and
treated.
Use of the veterinary medicinal product has not been evaluated in combination with
systemic immunosuppressive agents such as glucocorticoids, cyclosporine or other
immunosuppressive agents. Furthermore, the safety of the veterinary medicinal
product has not been investigated in dogs with evidence of immunosuppression (for
example, uncontrolled primary hypothyroidism, rickettsial disease) or dogs with
evidence of progressive malignant neoplasia. Use in such cases should be based on
a benefit-risk assessment by the responsible veterinarian.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Wash hands thoroughly with soap and water immediately after use of the veterinary
medicinal product.
Special precautions for the protection of the environment:
Not applicable.